Study S002074

The Effects of Exenatide on Post-Prandial Glucose Excursions and Vascular Health in Obese/Pre-Diabetic Young Adults

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00845559
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2008-08
Primary completion: 2010-03
Lead sponsor: Yale University
Conditions: Obesity; Insulin Resistance; Impaired Glucose Tolerance; Cardiovascular Disease
Interventions: DRUG:Exenatide
Results posted: FALSE

Registered primary outcomes

Whether treatment with exenatide attenuates post-prandial glycemic excursions as assessed by oral glucose tolerance testing (OGTT) and continuous monitoring system (CGMS) technology. [OGTT (Pre- and post-intervention), CGMS (Pre-intervention, 2-months and post-intervention)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.